The Centers for Disease Control and Prevention (CDC) recently formed a five-year cooperative agreement with the American Diabetes Association (ADA) to expand the National Diabetes Prevention Program (National DPP) in underserved, primarily rural areas.
Noting one patient’s observation that “no matter what I'm going through with lupus … chances are that someone online has also …,” the Lupus Foundation of America (LFA) recently expanded its support system, establishing the online LupusConnect.
After a decade of advocating research about the impact of lupus on military service, the Lupus Foundation of America recently announced the creation of a research program at the U.S. Defense Department, made possible by a $5 million endowment authorized by Congress this year.
Yale New Haven Transplantation Center said it recently completed one of biggest single-center kidney chain exchanges in the U.S. in which it matched nine donors and nine people who needed kidneys in kidney transplant procedures May 9 to June 21.
Lupus patient advocates are planning to hold the Lupus Patient-Focused Drug Development (PFDD) Meeting, titled Lupus: Patient Voices, on Sept. 25 in the Washington, D.C., area, a release on the Lupus Foundation of America website said.
Despite a history riddled with setbacks, lupus researchers may now be able to construct more effective clinical trials following the published results of a collaboration in drug product development, the Lupus Foundation of America said in a recent release.
The Research.forME Lupus Registry was recently launched to give those living with lupus and their caregivers the opportunity to share their experiences and locate new information on research and treatments, the Lupus Foundation of America said in a release.
The North Carolina Disposal Initiative (NCDI), which was recently formed by Purdue Pharma L.P., Project Lazarus and Safe Kids North Carolina, is focusing on supporting medicine disposal and evaluating the effectiveness of prevention programs on opioid abuse and overdoses.
The American Diabetes Association has issued guidelines on diabetes prevention, assessment and treatment in the article, "Diabetic Retinopathy: A Position Statement by the American Diabetes Association," which will be published in the March 2017 issue of Diabetes Care.
A combination drug therapy for the treatment of lung cancer has begun phase II testing with approximately 60 patients experiencing progression or relapse of the disease, Boehringer Ingelheim announced recently.